The MPA initiates research on vaccine safety and narcolepsy
The Medical Products Agency (MPA) has previously presented results from studies performed in Sweden on the safety of the pandemic vaccine Pandemrix. To further elucidate an association between narcolepsy and vaccination the MPA has initiated further research. The studies are coordinated by the MPA and are conducted both by in-house and by independent researchers and are expected to be ongoing during 2012.
Source: MPA RSS news - - Category: Medical Equipment Authors: Medical Products Agency, Sweden Source Type: news